Antimalarial activity of endoperoxide compound 6-(1,2,6,7-tetraoxaspiro[7.11]nonadec-4-yl)hexan-1-ol

Parasitology International

Volumn 60, Issue 3, 2011, Pages 270-273

  Sato, Akira ^a   Hiramoto, Akiko ^a   Morita, Masayuki ^a   Matsumoto, Masahiro ^a   Komich, Yuka ^a   Nakase, Yukari ^a   Tanigawa, Natsuki ^a   Hiraoka, Osamu ^b   Hiramoto, Kazuyuki ^b   Hayatsu, Hikoya ^a   Higaki, Kazutaka ^a   Kawai, Satoru ^c   Masuyama, Araki ^d   Nojima, Masatomo ^e   Wataya, Yusuke ^a   Kim, Hye Sook ^a  

^a OKAYAMA UNIVERSITY   (Japan)

^b SHUJITSU UNIVERSITY   (Japan)

^c DOKKYO MEDICAL UNIVERSITY   (Japan)

^d OSAKA INSTITUTE OF TECHNOLOGY   (Japan)

^e OSAKA UNIVERSITY   (Japan)

Author keywords

6 (1,2,6,7 tetraoxaspiro 7.11 nonadec 4 yl)hexan 1 ol (N 251); Antimalarial activity; Endoperoxide compound; Plasmodium berghei; Plasmodium falciparum

Indexed keywords

6 (1,2,6,7 TETRAOXASPIRO[7.11]NONADEC 4 YL)HEXAN 1 OL; ANTIMALARIAL AGENT; N 251; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIMALARIAL ACTIVITY; ARTICLE; CYTOTOXICITY; DIARRHEA; DRUG STRUCTURE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PARASITEMIA; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; RAT; SINGLE DRUG DOSE; WEIGHT REDUCTION;

ADMINISTRATION, ORAL; ANIMALS; ANTIMALARIALS; ARTEMISININS; CELL LINE, TUMOR; DRUG THERAPY, COMBINATION; ERYTHROCYTES; HETEROCYCLIC COMPOUNDS, 2-RING; HEXANOLS; HUMANS; MALARIA; MALARIA, FALCIPARUM; MICE; MICE, INBRED ICR; MOLECULAR STRUCTURE; PARASITEMIA; PARASITIC SENSITIVITY TESTS; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; RATS; SPIRO COMPOUNDS; SURVIVAL ANALYSIS;

MUS; PLASMODIUM BERGHEI; PLASMODIUM FALCIPARUM; RATTUS;

EID: 79959523974     PISSN: 13835769     EISSN: 18730329     Source Type: Journal    
DOI: 10.1016/j.parint.2011.04.001     Document Type: Article

References (9)

1. Ridley R.G. Medical need, scientific opportunity and the drive for antimalarial drugs. Nature 2002, 415:686-693.
2. Snow R.W., Guerra C.A., Noor A.M., Myint H.Y., Hay S.I. The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature 2005, 434:214-217.
3. Mita T., Tanabe K., Kita K. Spread and evolution of Plasmodium falciparum drug resistance. Parasitol Int 2009, 58:201-209.
4. Klayman D.L. Qinghaosu (artemisinin): an antimalarial drug from China. Science 1985, 228:1049-1055.
5. White N.J. Qinghaosu (artemisinin): the price of success. Science 2008, 320:330-334.
6. Noedl H., Se Y., Schaecher K., Smith B.L., Socheat D., Fukuda M.M. Evidence of artemisinin-resistant malaria in western Cambodia. N Engl J Med 2008, 359:2619-2620.
7. Dondorp A.M., Nosten F., Yi P., Das D., Phyo A.P., Tarning J., et al. Artemisinin resistance in Plasmodium falciparum malaria. N Engl J Med 2009, 361:455-467.
8. Kim H.S., Nagai Y., Ono K., Begum K., Wataya Y., Hamada Y., et al. Synthesis and antimalarial activity of novel medium-sized 1,2,4,5-tetraoxacycloalkanes. J Med Chem 2001, 44:2357-2361.
9. Kim H.S., Shibata Y., Wataya Y., Tsuchiya K., Masuyama A., Nojima M. Synthesis and antimalarial activity of cyclic peroxides, 1,2,4,5,7-pentoxocanes and 1,2,4,5-tetroxanes. J Med Chem 1999, 42:2604-2609.